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Abstract 
Background: Inflammation may be one of the pathways explaining 
differences in cardiometabolic risk between urban and rural residents. 
We investigated associations of inflammatory markers with rural 
versus urban residence, and with selected cardiometabolic 
parameters previously observed to differ between rural and urban 
residents: homeostatic model assessment of insulin resistance 
(HOMA-IR), fasting blood glucose (FBG), blood pressure (BP) and body 
mass index (BMI). 
Methods: From two community surveys conducted in Uganda, 313 
healthy individuals aged ≥ 10 years were selected by age- and sex-
stratified random sampling (rural Lake Victoria island communities, 
212; urban Entebbe municipality, 101). Fluorescence intensities of 
plasma cytokines and chemokines were measured using a bead-based 
multiplex immunoassay. We used linear regression to examine 
associations between the analytes and rural-urban residence and 
principal component analysis (PCA) to further investigate patterns in 
the relationships. Correlations between analytes and metabolic 
parameters were assessed using Pearson’s correlation coefficient. 
Results: The urban setting had higher mean levels of IL-5 (3.27 vs 
3.14, adjusted mean difference [95% confidence interval] 
0.12[0.01,0.23] p=0.04), IFN-  (26.80 vs 20.52, 6.30[2.18,10.41] 
p=0.003), EGF (5.67 vs 5.07, 0.60[0.32,0.98] p<0.00001), VEGF (3.68 vs 
3.28, 0.40[0.25,0.56] p<0.00001), CD40 Ligand (4.82 vs 4.51, 0.31[0.12, 
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0.50] p=0.001) and Serpin-E1 (9.57 vs 9.46, 0.11[0.05,0.17] p<0.00001), 
but lower levels of GMCSF (2.94 vs 3.05, -0.10[-0.19,-0.02] p=0.02), 
CCL2 (2.82 vs 3.10, -0.45[-0.70,-0.21] p<0.00001) and CXCL10 (5.48 vs 
5.96, -0.49[-0.71,-0.27] p<0.00001), compared to the rural setting. In 
PCA, the urban setting had lower representation of some classical 
inflammatory mediators but higher representation of various 
chemoattractants and vasoactive peptides. HOMA-IR, FBG, BP and 
BMI were positively correlated with several principal components 
characterised by pro-inflammatory analytes. 
Conclusions: In developing countries, immunological profiles differ 
between rural and urban environments. Differential expression of 
certain pro-inflammatory mediators may have important health 
consequences including contributing to increased cardiometabolic 
risk observed in the urban environment.
Keywords 
Rural, Urban, Inflammation, Cytokines, Immunoassay, Hypertension, 
Diabetes, Cardiometabolic, Africa
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Introduction
Inflammation is a necessary component of the immune system 
response to injury and infection. However, chronic, low-
grade inflammation has been implicated in the development 
and progression of cardiometabolic disorders such as type 2 
diabetes1 and atherosclerosis2. The burden of these diseases is 
increasing globally with cardiovascular diseases being the top 
contributors to global mortality and morbidity3,4. This increase 
has been attributed to changes in lifestyle and diet as a result 
of urbanisation and the burden is heavier among individu-
als in urban areas. Currently, more than 50% of the world’s 
population lives in urban areas and this is expected to increase5. 
Environmental exposures such as microbial exposure, helminth 
infections, diet and pollution influence the inflammatory status 
of individuals. This may lead to differences in immune status 
between individuals in rural and urban settings6. Therefore, 
inflammation may be one of the pathways explaining the dispar-
ity in cardiometabolic disease burden and risk between rural 
and urban areas.
Few studies have investigated, in the general population, rural- 
urban differences in inflammatory markers. A study in Sen-
egal showed that urban inhabitants had lower pro-inflammatory 
and T-cell activation profiles than rural inhabitants6. Another 
study in Morocco investigating gene expression in blood 
leukocyte samples showed differences in the leukocyte tran-
scriptome among rural, urban and nomadic populations7. Other 
studies have focused on particular disease states and the results 
are mixed and inconsistent. For example, compared with 
rural upbringing, urban upbringing has been associated with 
higher concentrations of the pro-inflammatory cytokine inter-
leukin (IL)-6 and suppressed concentrations of the anti- 
inflammatory cytokine IL-10 following acute social stress8. 
A study investigating the effect of exposure to a forest envi-
ronment on stress levels and cytokines showed that, compared 
with two hours of forest exposure, urban exposure for two 
hours resulted in higher levels of the chemokine IL-8 and the 
pro-inflammatory cytokine tumour necrosis factor (TNF)-alpha9. 
In the investigation of diabetes risk in India, urban dwellers had 
higher levels of TNF-alpha, IL-6 and the adipokine leptin than 
rural dwellers10. A study conducted in Ghana among individu-
als with type 2 diabetes showed higher levels of TNF-alpha 
but lower levels of IL-6 among urban participants than in rural 
participants11. Conversely, plasma levels of the chemoattract-
ant C-C motif chemokine (CCL) 11 have been shown to be 
lower in urban, compared to rural dwellers in a study investigat-
ing the effect of CCL on cognitive function12. Among individuals 
with atopy, urban inhabitants had higher levels of gene expres-
sion for IL-4R, a type 2 cytokine receptor, compared with rural 
inhabitants13. In another study in Ghana, urban children had 
increased gene expression of IL-10 compared with rural 
children, irrespective of helminth infection status14.
Different environments exert different influences on the immune 
status of the inhabitants. To our knowledge, no study has inves-
tigated rural-urban differences in inflammatory markers 
in Uganda or explored the implications of rural-urban differ-
ences for cardiometabolic risk. We, therefore, exploited a unique 
opportunity to measure inflammatory markers from individuals 
living in a rural and urban setting. We investigated rural-urban 
differences in inflammatory cytokines and chemokines and 
examined correlations between the inflammatory markers and 
the metabolic parameters HOMA-IR, fasting blood glucose, 
blood pressure and body mass index (BMI), which we had 
found to be different between the urban and rural settings15.
Methods
Study design and setting
This was a cross-sectional comparative study. We measured 
pro- and anti-inflammatory cytokines and chemokines in stored 
plasma of individuals who participated in two cross-sectional 
surveys conducted in rural and urban Uganda. The rural sur-
vey was conducted from April to December 2017 in 26 island 
fishing communities in Lake Victoria, Koome sub-county, 
Mukono district as part of the Lake Victoria Island Interven-
tion Study on Worms and Allergy-related related diseases (LaVI-
ISWA). These fishing villages are located on the shores of the 
islands and have a high burden of schistosomiasis. LaVI-
ISWA was a cluster-randomised trial designed to investigate 
the effects of community-wide intensive (quarterly single-dose 
praziquantel and triple-dose albendazole) versus standard (annual 
single-dose praziquantel and six-monthly single-dose alben-
dazole) anthelminthic intervention on health outcomes16,17. 
The LaVIISWA protocol has been published18. This survey, 
the rural metabolic survey, was conducted in participants aged 
≥10 years after four years of the anthelminthic intervention 
to investigate its effects on metabolic outcomes16. The urban sur-
vey was conducted between September 2016 and September 
2017 in 23 sub-wards of Entebbe municipality, Wakiso district, 
Uganda. Entebbe is located on a peninsula on the northern shore 
of Lake Victoria. The urban survey was a cross-sectional study 
that collected data on allergy-related and metabolic outcomes19. 
In both surveys, data were collected on sociodemographic char-
acteristics (obtained using a questionnaire), fasting plasma 
glucose, fasting lipid profile (triglycerides, total cholesterol, 
high-density lipoprotein [HDL]-cholesterol and low-density 
lipoprotein [LDL]-cholesterol), blood pressure, body mass 
index, waist and hip circumference. The field tools and proce-
dures in both surveys were aligned to enable a comparison of the 
outcomes between the two surveys.
Participants and samples
We used plasma samples from 313 healthy participants, 212 
from the rural setting (104 from the intensive arm and 108 from 
the standard arm of the LaVIISWA trial) and 101 from the 
urban setting. These were randomly selected from each sur-
vey using STATA software (STATA v13, College Station, Texas, 
USA). No formal sample size calculation was performed 
because this work was exploratory. Participants with incom-
plete data on helminth infection status, blood pressure, glucose, 
insulin, lipid profile, BMI, waist and hip circumference or did 
not have stored plasma samples were excluded from the sam-
pling frame. The selection was stratified by age (10–19 years, 
20–29 years, 30–39 years and ≥40 years) and sex. This was to 
ensure that the age and sex distribution of participants whose 
samples were used was similar between the two settings because 
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age and sex might be predictive of inflammatory marker lev-
els. Stored plasma samples were retrieved and cytokines/ 
chemokines measured using a bead-based multiplex immunoassay 
(Luminex).
Measurement of inflammatory markers
We measured the fluorescence intensity and concentrations 
of 30 analytes in plasma. Commercially available kits which 
included chemokines, Th1 and Th2 cytokines, and adipokines 
were selected. The analytes measured were adiponectin/Acrp30, 
serpin E1/PAI1, chemokine (C-C motif) ligand (CCL)2/JE/ 
monocyte chemoattractant protein (MCP)1, CCL3/MIP1-
alpha, CCL4/MIP1-beta, CCL11/Eotaxin, CCL22/MDC, CD40 
Ligand/TNFSF5, chemokine (C-X-C motif) ligand (CXCL)1/
GRO-alpha/KC, CXCL2/Gro-beta/MIP2/CINC3, CXCL10/ 
interferon-gamma induced protein (IP)10/CRG2, epidermal 
growth factor (EGF), Fas, granulocyte-macrophage colony-stim-
ulating factor (GMCSF), interferon (IFN)-alpha, IFN-gamma, 
Interleukin (IL) 1-alpha, IL-1beta/IL-1F2, IL-2, IL-4, IL-5, IL-6, 
IL-8/CXCL8, IL-10, IL-12 p70, IL-13, IL-17/IL-17A, leptin, 
tumour necrosis factor (TNF)-alpha and vascular endothelial 
growth factor (VEGF)-C.
Plasma samples, stored in -80 degrees Celsius refrigerators, 
were thawed to room temperature and tested. The multiplex 
assays were performed using the Human Premixed Multi-analyte 
Magnetic Luminex Assay kit (R and D Systems Inc, Minneapolis, 
Minnesota, USA; catalogue numbers, LXSAHM-01, LXSAHM-
02, LXSAHM-27; Lot numbers L128094-6) according to 
the manufacturer’s instructions. The thirty analytes were assessed 
using three panels, a one-plex assay for VEGF, a two-plex 
assay for adiponectin and serpin E1 and a 27-plex assay for the 
other analytes. In brief, all reagents were prepared as instructed 
by the kit manufacturer. To each well, 50ul of sample (or stand-
ard) were added followed by 50ul of diluted Microparticle 
Cocktail. The mixture was incubated on a shaker for two hours 
and washed with wash buffer three times. Diluted Biotin- 
Antibody Cocktail was added (50ul to each well), incubated on 
the shaker and washed with wash buffer three times. Thereafter, 
diluted Streptavidin-PE was added (50ul to each well), incu-
bated on the shaker for 30 minutes and again washed three times. 
Wash buffer was then added to each well and incubated for two 
minutes on a shaker. All incubations were at room temperature 
and each time, the shaker was rotating at 800 rpm.
The results were read using the Bio-Plex 200 System (Bio-
Rad Laboratories, Hercules, California, USA) and the Bio-Plex 
Manager software (version 6.0; Bio-Rad Laboratories, Her-
cules, California, USA) after imputing the assay working range 
(lower and upper limits of quantification) for each analyte 
according to the manufacturer’s instructions. Raw fluorescence 
intensity values and observed concentrations were obtained.
Statistical methods
The analyses were performed using STATA version 13.0 
(College Station, Texas). The 30 cytokines/chemokines were 
the outcomes of interest in this analysis. The exposures of inter-
est were the rural-urban setting and the metabolic parameters 
homeostatic model assessment of insulin resistance (HOMA-IR), 
fasting plasma glucose, blood pressure and body mass index 
(BMI). In all our analyses, we used the raw fluorescence inten-
sity values of the cytokines. This is because the analytes were 
predominantly low in abundance and the observed concentra-
tions were mostly extrapolated beyond the standard range. 
Using the observed concentrations would require censoring 
i.e. not assigning values for concentrations that are out of the 
standard range. This would affect most of the cytokines meas-
ured and therefore limit the statistical power of the analysis. 
Analysis using fluorescence intensities does not require cen-
soring and provides more statistical power than analysis based 
on concentrations. It also does not require correction for 
background fluorescence because the automatic calibration 
steps produce a highly reproducible signal even across differ-
ent Luminex machines. This approach for analysing Luminex 
data has been validated20,21 and used previously22,23.
The fluorescence intensities of cytokines were compared 
between the rural and urban setting. All analyte intensities were 
first log-transformed. The mean log intensity of each analyte 
in each setting was then calculated and regression models fit-
ted to assess for differences. Crude and adjusted mean dif-
ferences (adjusted for age and sex) and their 95% confidence 
intervals are presented. Further analyses investigated correla-
tion patterns between the outcomes and then used principal com-
ponent analysis to transform from a set of correlated outcome 
variables to a set of uncorrelated variables (linear combinations 
of the original outcomes) aiming to capture as much variabil-
ity as possible with the first few components. The newly gener-
ated uncorrelated variables were then compared between the 
settings. Selection of the number of principal components to 
retain was based on the Kayser criterion, therefore, components 
with an eigenvalue of ≥1 were retained. A scree plot was con-
structed to give a visual representation of the PCA eigenvalues. 
In the interpretation of the principal components, we com-
puted the unrotated matrix containing the factor loadings of 
each variable for each component. For each variable, the prin-
cipal component with the highest loading for that variable was 
interpreted as representative of the variable (adapted from 24). 
In all the analyses, data from the rural setting included all 
rural participants regardless of LaVIISWA trial arm. This is 
because no strong differences in the cytokines were found 
between the study arms.
To determine the relationship between cytokines/chemokines 
and metabolic parameters we computed Pearson correlation 
coefficients. This is to investigate the strength and direction 
of any linear relationship. We obtained coefficients for the cor-
relation of the log-transformed intensity for each analyte with 
HOMA-IR, fasting plasma glucose, blood pressure (systolic 
and diastolic) and BMI. We also correlated the metabolic 
outcomes with the retained components from the PCA. Cor-
relation coefficients and their p-values are reported. No formal 
adjustment was made for multiple testing.
Ethical approvals and consent
Ethical clearance for this work was obtained from the Uganda 
Virus Research Institute Research Ethics Committee (refer-
ence number GC/127/17/01/573), the Uganda National Council 
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for Science and Technology (reference number HS 2185) and 
the London School of Hygiene and Tropical Medicine Research 
Ethics Committee (reference number 9917). All participants 
provided written informed consent to participate in the sur-
veys and have their samples stored for this work (see consent 
forms and information sheets in the extended data25).
Results
Characteristics of the participants
The characteristics of the participants selected for this analy-
sis are shown in Table 125. Samples from 313 participants 
(rural, 212; urban, 101) were analysed. The participants had 
a median age of 30 years and were selected to have compara-
ble distributions of age and sex. Participants in the urban setting 
had a lower prevalence of the helminths Schistosoma mansoni 
(28.7% vs 53.6%) and Trichuris trichiura (1.0% vs 9.5%) 
than those in the rural setting.
Associations between the analytes and study setting
The associations (both unadjusted and adjusted) between rural-
urban setting and level of each analyte are shown in Table 2. 
Somewhat higher levels of the Th2 associated cytokine IL-5 
were observed in the urban setting on adjusted analysis (3.27 
vs 3.14, adjusted mean difference [95% confidence interval] 
0.12 [0.01, 0.23] p=0.04). However, no differences were observed 
for the other Th2 associated cytokines (IL-4 and IL-13), Th1 
associated cytokines (IL-2, IFN-gamma and TNF-alpha), Th17 
associated cytokines (IL-17) or the regulatory cytokines (IL-10, 
TGF-beta) between the rural and urban settings. Furthermore, 
no differences were observed for the adipokines adiponectin 
and leptin.
Comparison of chemokines, growth factors and other cytokines 
between the rural and urban setting showed interesting dif-
ferences. Individuals in the urban setting had higher levels of 
Table 1. Characteristics of the study participants.
Urban setting
Rural setting
Overall Standard arm Intensive arm
Sex, male 50/101 (49.5%) 108/212 (50.9%) 55/108 (50.9%) 53/104 (51.0%)
Age (median, IQR) 30 (20.0, 39.0) 30 (20.0, 38.5) 30 (20, 40) 29 (20, 37.5)
Age group
10–19yrs 25/101 (24.8%) 51/212 (24.1%) 26/108 (24.1%) 25/104 (24.0%)
20–29yrs 25/101 (24.8%) 54/212 (25.5%) 26/108 (24.1%) 28/104 (25.9%)
30–39yrs 26/101 (25.7%) 55/212 (25.9%) 28/108 (25.9%) 27/104 (26.0%)
40+ 25/101 (24.8%) 52/212 (24.5%) 28/108 (25.9%) 24/104 (23.1%)
Schistosoma mansoni, stool Kato Katz* 10/101 (9.9%) 73/211 (34.6%) 35/107 (32.7%) 38/104 (36.5%)
Schistosoma mansoni, stool PCR* 29/101 (28.7%) 113/211 (53.6%) 61/107 (57.0%) 52/104 (50.0%)
Hookworm, stool Kato Katz* 2/101 (2.0%) 6/211 (2.8%) 3/107 (2.8%) 3/104 (2.9%)
Hookworm, stool PCR* 2/101 (2.0%) 8/194 (4.1%) 4/104 (3.9%) 4/90 (4.4%)
Trichuris trichiura, stool Kato Katz* 1/101 (1.0%) 20/211 (9.5%) 15/107 (14.0%) 5/104 (4.8%)
Ascaris lumbricoides, stool Kato Katz* 0 2/211 (1.0%) 2/107 (1.9%) 0
Mansonella perstans, modified Knott’s* 2/101 (2.0%) 6/211 (2.8%) 2/107 (1.9%) 4/104 (3.9%)
Strongyloides stercoralis, stool PCR* 4/101 (4.0%) 14/211 (6.6%) 8/107 (7.5%) 6/104 (5.8%)
HOMA-IR (mean, SD)** 1.72 (2.0) 1.77 (1.4) 1.65 (1.2) 1.89 (1.6)
Fasting blood glucose mmol/L (mean, SD)** 4.64 (0.8) 4.79 (0.7) 4.75 (0.8) 4.83 (0.6)
Systolic blood pressure, mmHg (mean, SD)** 117.29 (13.0) 114.48 (14.9) 113.48 (16.3) 115.51 (13.3)
Diastolic blood pressure, mmHg (mean, SD)** 76.56 (9.9) 75.46 (10.5) 74.90 (10.6) 76.04 (10.4)
Body mass index, kg/m2 (mean, SD)** 23.81 (5.7) 22.89 (4.2) 22.43 (3.9) 23.36 (4.4)
IQR, Interquartile range; SD, Standard deviation; PCR, Polymerase chain reaction; HOMA-IR, Homeostatic model assessment of insulin resistance; 
*Results of chi-squared tests for whether participant characteristics differed between urban and rural setting were: Schistosoma mansoni stool 
Kato Katz (p=<0.001); Schistosoma mansoni stool PCR (p=<0.001), Hookworm stool Kato Katz (p=0.652), Hookworm stool PCR (p=0.334), Trichuris 
trichiura (p=0.005), Ascaris lumbricoides (p=0.326), Mansonella perstans (p=0.652) Strongyloides stercoralis (p=0.343); **Results of two-sample 
t-tests for whether participant characteristics differed between urban and rural setting were: HOMA-IR (p=0.815), Fasting blood glucose (p=0.084), 
Systolic blood pressure (p=0.105), Diastolic blood pressure (p=0.380), Body mass index (p=0.108).
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Table 2. Associations between inflammatory analyte intensities and study setting.
Analytes
Mean log 
fluorescence 
intensity*
Mean difference (95% CI)
Rural Urban Unadjusted P value Adjusted for age and sex P value
IL1-alpha 2.91 2.88 -0.03 (-0.10, 0.03) 0.32 -0.03 (-0.10, 0.03) 0.33
IL1-beta 2.52 2.58 0.05 (-0.07, 0.18) 0.39 0.05 (-0.07, 0.18) 0.40
IL-2 2.98 2.97 -0.01 (-0.08, 0.06) 0.76 -0.01 (-0.08, 0.06) 0.76
IL-4 2.92 2.93 0.00 (-0.04, 0.05) 0.91 0.00 (-0.04, 0.05) 0.89
IL-5 3.14 3.27 0.13 (-0.01, 0.26) 0.06 0.12 (0.01, 0.23) 0.04
IL-6 3.04 3.00 -0.04 (-0.19, 0.11) 0.58 -0.04 (-0.19, 0.11) 0.57
IL-10 3.52 3.43 -0.09 (-0.19, 0.01) 0.06 -0.09 (-0.19, 0.00) 0.06
IL-12 p70 2.98 2.99 0.01 (-0.05, 0.07) 0.84 0.01 (-0.05, 0.07) 0.82
IL-13 3.15 3.17 0.02 (-0.04, 0.07) 0.51 0.02 (-0.04, 0.07) 0.50
IL-17 2.35 2.35 0.00 (-0.05, 0.04) 0.85 0.00 (-0.05, 0.04) 0.84
TNF-alpha 3.04 2.94 -0.10 (-0.23, 0.03) 0.12 -0.10 (-0.23, 0.03) 0.119
VEGF-C 3.28 3.68 0.40 (0.24, 0.56) <0.0001 0.40 (0.25, 0.56) <0.0001
IFN-alpha 20.52 26.80 6.28 (2.20, 10.37) 0.003 6.30 (2.18, 10.41) 0.003
IFN-gamma 2.84 2.82 -0.02 (-0.08, 0.04) 0.43 -0.02 (-0.08, 0.04) 0.43
CD40L 4.51 4.82 0.31 (0.12, 0.50) 0.001 0.31 (0.12, 0.50) 0.001
serpin E1 9.46 9.57 0.11 (0.05, 0.17) 0.0003 0.11 (0.05, 0.17) <0.0001
EGF 5.07 5.67 0.61 (0.33, 0.89) <0.0001 0.60 (0.32, 0.89) <0.0001
Fas 7.52 7.39 -0.13 (-0.31, 0.05) 0.16 -0.13 (-0.31, 0.06) 0.17
GMCSF 3.05 2.94 -0.10 (-0.19, -0.02) 0.016 -0.10 (-0.19, -0.02) 0.02
CCL2 3.10 2.82 -0.28 (-0.46, -0.10) 0.002 -0.45 (-0.70, -0.21) <0.0001
CCL3 2.72 2.82 0.10 (-0.10, 0.10) 0.32 0.10 (-0.10, 0.30) 0.31
CCL4 2.92 2.91 -0.01 (-0.14, 0.12) 0.88 -0.02 (-0.19, 0.16) 0.85
CCL11 3.16 3.14 -0.02 (-0.07, 0.03) 0.49 -0.02 (-0.07, 0.04) 0.51
CCL22 5.69 5.61 -0.08 (-0.40, 0.25) 0.64 -0.08 (-0.38, 0.22) 0.60
CXCL1 3.15 3.35 0.20 (-0.02, 0.42) 0.07 0.20 (-0.02, 0.42) 0.07
CXCL2 4.87 5.52 0.65 (0.27, 1.04) 0.001 0.56 (0.20, 0.92) 0.003
CXCL10 5.96 5.48 -0.48 (-0.70, -0.26) <0.0001 -0.49 (-0.71, -0.27) <0.0001
IL-8/CXCL8 3.44 3.36 -0.08 (-0.31, 0.15) 0.48 -0.08 (-0.31, 0.15) 0.48
Adiponectin 9.30 9.32 0.02 (-0.07, 0.11) 0.69 0.02 (-0.07, 0.11) 0.69
Leptin 5.19 5.53 0.35 (-0.11, 0.80) 0.14 0.31 (-0.02, 0.63) 0.06
CI, Confidence interval; * log transformed because of skewed data
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IFN-alpha, a member of the type 1 interferon family secreted in 
response to viral infection (26.80 vs 20.52, 6.30 [2.18, 10.41] 
p=0.003). Participants in the urban setting also had higher 
levels of the growth factors EGF (5.67 vs 5.07, 0.60 [0.32, 0.98] 
p<0.00001) and VEGF (3.68 vs 3.28, 0.40 [0.25, 0.56] p<0.00001), 
and CD40L, a member of the TNF superfamily involved 
in B-cell activation and class-switching (4.82 vs 4.51, 0.31 
[0.12, 0.50] p=0.001). Higher levels of serpin E1, an inhibi-
tor of tissue plasminogen activator and urokinase, were also 
observed in the urban setting (9.57 vs 9.46, 0.11 [0.05, 0.17] 
p<0.00001). Conversely, participants in the urban setting had 
lower levels of GMCSF (2.94 vs 3.05, -0.10 [-0.19, -0.02] p=0.02) 
and the chemokines CCL2 (2.82 vs 3.10, -0.45 [-0.70, -0.21] 
p<0.00001) and CXCL10 (5.48 vs 5.96, -0.49 [-0.71, -0.27] 
p<0.00001). However, the levels of the chemokine CXCL2 
were higher in the urban setting (5.52 vs 4.87, 0.56 [0.20, 0.92] 
p=0.003). No differences were observed for the other analytes.
Associations between the analytes and selected 
metabolic parameters
The correlations between the analytes and metabolic parameters 
are shown in Table 3. There was a positive correlation between 
insulin resistance (HOMA-IR) and the pro-inflammatory 
analytes CCL22, CXCL1, IL-5, IL-17 and Leptin. Similarly, 
fasting blood glucose was positively correlated with IL-5, 
IL-17 and Leptin. Systolic blood pressure and diastolic blood 
pressure were positively correlated with VEGF-C and Lep-
tin respectively. BMI was positively correlated with IL-5 and 
Leptin but negatively correlated with CCL22.
Principal component analysis
Correlations were observed among the analytes and the dataset 
was summarised using principal component analysis. On princi-
pal component analysis, six principal components were retained 
and these accounted for 73% of the variance in the origi-
nal 30 outcomes. The scree plot constructed to give a visual 
representation of the PCA eigenvalues is shown in Figure 1.
The resulting principal components were challenging to inter-
pret and did not represent any immediately obvious standard 
classifications. The first component explained 38% of the 
total variance and was constituted by CCL3, CCL11, CD40 
Ligand, Fas, IFN-alpha, IFN-gamma, IL1-alpha, IL-2, IL-12 and 
IL-13. These are a mixed selection of chemoattractants, cytokines 
and chemokines generally associated with inflammation. All 
the analytes in this component had positive loadings (coef-
ficients). The second principal component explained a further 
13% of the variance in the 30 outcomes and was character-
ised by chemoattractants and vasoactive mediators Serpin E1, 
CXCL1, CXCL2, CXCL10, EGF, GMCSF and VEGF-C (all had 
positive loadings except for GMCSF and CXCL10). The third 
principal component was characterised by negative loadings 
(coefficients) of CCL4, IL-8/CXCL8, and the classical mark-
ers of inflammation, IL1-beta, IL-6, and TNF-alpha, and 
explained a further 9% of the variance. The other compo-
nents and variables contributing to them are shown in Table 4. 
Associations between the principal components and study set-
ting are shown in Table 5 and Figure 2 and Figure 3. Compared 
with the rural setting, the urban setting had higher scores for 
principal component 2, implying higher representation of 
chemoattractants and vasoactive mediators among individuals in the 
Table 3. Correlations between inflammatory analytes and 
metabolic parameters.
Analyte HOMA-IR FBG SBP DBP BMI
IL1-alpha 0.06 0.02 0.10 0.04 -0.03
IL1-beta 0.04 0.00 0.10 0.05 0.08
IL-2 0.11* 0.05 0.07 0.03 0.03
IL-4 0.04 0.11 0.10 0.04 0.01
IL-5 0.34*** 0.15** 0.02 0.13* 0.58***
IL-6 0.06 0.03 0.02 0.02 0.04
IL-10 0.07 -0.02 -0.08 -0.13* -0.07
IL-12 0.01 -0.02 0.10 0.08 0.02
IL-13 0.04 0.02 0.09 0.02 -0.04
IL-17 0.12* 0.18** 0.05 0.04 0.00
TNF-alpha 0.07 0.03 0.02 0.05 0.01
VEGF-C 0.02 -0.12* 0.21** 0.11 0.12
IFN-alpha 0.10 0.05 0.10 0.06 0.15*
IFN-gamma 0.13* 0.09 0.07 0.03 0.00
CD40L 0.06 -0.02 0.12* 0.02 0.07
Serpin E1 0.02 -0.01 0.12* 0.09 0.10
EGF 0.05 -0.03 0.12* 0.02 0.08
Fas 0.04 0.09 0.14* 0.05 0.00
GMCSF 0.08 0.09 -0.03 0.00 -0.02
CCL2 0.00 0.07 0.07 0.13* 0.02
CCL3 0.05 -0.01 0.12* 0.05 -0.01
CCL4 0.07 0.00 0.10 0.07 0.05
CCL11 0.07 0.14* 0.08 0.07 0.04
CCL22 0.17** 0.08 -0.12* -0.13* -0.17**
CXCL1 0.17** 0.02 0.15* 0.06 0.10
CXCL2 0.10 -0.02 0.10 0.02 0.10
CXCL10 0.08 0.09 -0.07 -0.03 -0.06
IL-8/CXCL8 0.04 -0.05 0.07 0.03 0.04
Adiponectin -0.03 0.01 0.03 0.01 -0.01
Leptin 0.37*** 0.18** -0.03 0.15** 0.58***
*Correlation coefficient with 0.01≤p<0.05; **Correlation coefficient with 
0.001≤p<0.01; ***Correlation coefficient with p<0.001; HOMAIR, Homeostatic 
Model Assessment of Insulin Resistance; FBG, Fasting blood glucose; SBP, 
Systolic blood pressure; DBP, Diastolic blood pressure; BMI, Body mass index
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Table 4. Principal components and variables 
contributing to them.
Analyte PC1 PC2 PC3 PC4 PC5 PC6
IL1-alpha 0.22 -0.03 -0.12 -0.15 -0.04 0.08
IL1-beta 0.21 0.11 -0.31 0.09 -0.03 -0.01
IL-2 0.24 -0.07 -0.11 0.02 -0.01 0.01
IL-4 0.20 -0.11 0.08 -0.11 -0.28 0.19
IL-5 0.13 -0.07 0.22 0.60 0.02 0.07
IL-6 0.19 0.05 -0.40 0.16 0.03 -0.06
IL-10 0.19 -0.21 0.10 -0.05 0.23 -0.17
IL-12 0.20 -0.16 0.08 -0.06 -0.20 0.14
IL-13 0.22 -0.15 0.11 -0.09 -0.21 0.08
IL-17 0.18 -0.11 0.07 -0.03 -0.21 0.29
TNF-alpha 0.21 0.06 -0.33 0.10 0.02 -0.04
VEGF-C 0.12 0.34 0.21 -0.11 0.13 -0.08
IFN-alpha 0.17 0.13 0.10 0.04 -0.07 -0.10
IFN-gamma 0.21 -0.10 -0.02 -0.05 -0.09 0.14
CD40 Ligand 0.23 0.22 0.20 -0.07 0.03 -0.03
Figure 1. Scree plot of eigenvalues after principal component analysis. CI, Confidence interval.
Analyte PC1 PC2 PC3 PC4 PC5 PC6
serpin E1 0.11 0.29 0.15 -0.01 0.13 0.08
EGF 0.20 0.25 0.23 -0.04 0.03 -0.04
Fas 0.22 -0.20 0.10 -0.08 -0.10 0.04
GMCSF 0.17 -0.29 0.08 -0.05 0.25 -0.22
CCL2 0.13 -0.17 -0.05 -0.05 0.36 -0.17
CCL3 0.17 0.15 -0.16 0.00 -0.09 0.02
CCL4 0.23 0.10 -0.27 0.06 0.01 -0.02
CCL11 0.22 -0.17 0.14 -0.09 -0.12 0.04
CCL22 0.12 -0.04 0.14 -0.20 0.24 -0.10
CXCL1 0.15 0.28 0.11 -0.04 0.04 -0.03
CXCL2 0.18 0.29 0.19 -0.01 0.05 -0.11
CXCL10 0.14 -0.35 0.01 0.00 0.28 -0.20
IL-8/CXCL8 0.20 0.15 -0.30 0.07 0.05 -0.07
Adiponectin 0.01 0.02 -0.05 -0.05 0.56 0.78
Leptin 0.07 -0.06 0.21 0.67 0.04 0.04
PC, Principal component; The numbers in the table show, for each PC, the 
coefficients corresponding to each analyte. For each analyte, the PC with the 
highest loading (in bold) was interpreted as representative of that analyte.
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Figure 2. Principal component analysis biplot of components 1 and 2. Blue, Rural residents; Red, Urban residents.
Table 5. Associations between the principal components and study setting.
Setting Unadjusted Adjusted for age and sex
Rural Urban Mean difference (95% CI) P value
Mean difference 
95% CI P value
PC1 -0.07 0.15 0.23 (-0.58, 1.04) 0.58 0.23 (-0.59, 1.04) 0.59
PC2 -0.37 0.77 1.14 (0.68, 1.60) <0.00001 1.14 (0.68, 1.60) <0.00001
PC3 -0.21 0.43 0.64 (0.26, 1.02) 0.001 0.64 (0.26, 1.01) 0.001
PC4 -0.07 0.14 0.21 (-0.10, 0.51) 0.18 0.18 (-0.04, 0.40) 0.10
PC5 0.07 -0.15 -0.22 (-0.47, 0.02) 0.07 -0.23 (-0.47, 0.01) 0.06
PC6 -0.06 0.13 0.19 (-0.05, 0.43) 0.13 0.19 (-0.05, 0.43) 0.12
CI, Confidence interval; PC, Principal component
urban setting. The urban setting also had higher scores for 
principal component 3. This implies that there is lower 
representation of the classical inflammatory mediators IL1-beta, 
IL-6 and TNF-alpha in the urban setting compared to the 
rural setting (considering the negative coefficients shown in 
Table 4).
Associations between the principal components and meta-
bolic parameters are shown in Table 6. Principal component 4 
(characterised by IL-5 and Leptin) was positively correlated 
with HOMA-IR, fasting blood glucose, diastolic blood pressure 
and BMI. The strongest correlations were observed with BMI 
(correlation coefficient 0.61, p<0.0001) and HOMA-IR (0.31, 
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p<0.0001). Other significant correlations were found between 
principal component 1 and HOMA-IR (0.13, p=0.02), princi-
pal component 2 and systolic blood pressure (0.12, p=0.04), and 
principal component 3 and BMI (0.17, p=0.003).
Discussion
In this paper, we have shown that, compared with the rural envi-
ronment, the urban environment was associated with higher 
levels of pro-inflammatory chemokines: EGF, VEGF-C, CD40L, 
Figure 3. Principal component analysis biplot of components 2 and 3. Blue, Rural residents; Red, Urban residents.
Table 6. Associations between the principal components and metabolic parameters.
Component HOMA-IR FBG SBP DBP BMI
coeff. P-value coeff. P-value coeff. P-value coeff. P-value coeff. P- value
PC1 0.13 0.02 0.05 0.34 0.11 0.05 0.06 0.33 0.07 0.20
PC2 -0.02 0.67 -0.11 0.05 0.12 0.04 0.06 0.33 0.08 0.18
PC3 0.11 0.06 0.06 0.33 0.03 0.57 0.03 0.63 0.17 0.003
PC4 0.31 <0.0001 0.13 0.02 -0.05 0.40 0.14 0.01 0.61 <0.0001
PC5 0.05 0.41 -0.03 0.63 -0.09 0.11 -0.04 0.44 -0.01 0.89
PC6 -0.02 0.74 0.07 0.21 0.10 0.09 0.07 0.21 0.06 0.31
PC, Principal component; HOMAIR, Homeostatic Model Assessment of Insulin Resistance; FBG, Fasting blood glucose; SBP, Systolic 
blood pressure; DBP, Diastolic blood pressure; BMI, Body mass index
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serpin E1 but lower levels of GMCSF, CCL2 and CXCL10. 
Furthermore, the rural environment was associated with lower 
levels of the Th2 cytokine IL-5 but there was no difference 
in the other Th2, Th1, Th17 and regulatory cytokines between 
the settings. On principal component analysis, the urban envi-
ronment had higher representation of chemoattractants and 
vasoactive mediators (PC2) but lower representation of the clas-
sical inflammatory mediators (PC3). The metabolic parameters 
HOMA-IR, fasting blood glucose, blood pressure and BMI 
correlated positively with a largely distinct set of principal 
components characterised by pro-inflammatory analytes.
It was interesting to find that the levels of the growth 
factors EGF and VEGF-C were higher in the urban setting. EGF 
is a pro-inflammatory peptide that stimulates cell growth and 
proliferation. VEGF-C promotes lymphangiogenesis by direct-
ing the proliferation and migration of lymphatic epithelial cells 
and is also involved in the stimulation of growth of vascular 
tissue26. We also found lower levels of soluble CD40L in 
the rural compared with the urban population. CD40L is a 
pro-inflammatory molecule found both in a soluble form and 
expressed on activated T lymphocytes. It is pro-inflammatory to 
endothelial cells, has been suggested to be a marker of athero-
genesis27 and is elevated in individuals with diabetes, metabolic 
syndrome and insulin resistance27. The higher levels of these 
cytokines in the urban setting is consistent with the higher 
burden of these conditions in urban settings.
We found higher levels of serpin E1 in the urban setting 
compared to the rural setting and this is consistent with findings 
elsewhere28. Serpins have a role in inflammation and immune 
function. Serpin E1, also known as plasminogen inhibitor 1, 
is a serine protease inhibitor that inhibits tissue plasminogen 
inhibitor and urokinase, which are activators of plasminogen 
and fibrinolysis. Increased levels of serpin E1 are a risk factor 
for atherosclerosis and thrombosis30 and evidence suggests that 
increased levels accelerate vascular disease in patients with 
diabetes31,32. The lower levels of serpin E1, therefore, accord 
with evidence that that the rural environment has lower 
cardiovascular risk than the urban environment. Serpin E1 levels 
have been found to positively correlate with insulin resistance33 
but we did not find that in our study. On data reduction by 
principal component analysis, the individual findings were 
supported by higher levels of PC2 (characterised by various 
chemoattractants and vasoactive peptides) in the urban, compared 
to the rural environment.
The rural environment is associated with a higher microbial and 
parasite load and burden of chronic and recurrent infections34. 
It was therefore surprising to find no differences in the Th1, 
Th2, Th17 cytokines except for lower levels of IL-5 in the rural 
population compared to the urban population. Despite the 
higher burden of helminth infections in this rural setting15, 
there was no difference in the regulatory cytokines IL-10 and 
TGF-beta between the settings. It is possible that there is 
substantial exposure of individuals in this particular urban 
setting to infectious agents (both current and previous) sufficient 
to achieve a similar regulatory profile to individuals in the 
rural setting. Owing to the complexity of the distribution of 
antigens which trigger the immune response, investigating 
cellular profiles and responses to stimulation, to complement 
studies of plasma levels of cytokines, would be necessary to 
obtain a fuller understanding of immunological profiles in 
different settings. For example, contrary to our findings, a 
study in Senegal found that rural individuals had significantly 
higher expression of Th1, Th2, and Th22 cells compared to the 
urban population in response to stimulation6.
In contrast, we found lower levels of the pro-inflammatory 
analytes GMCSF, CCL2 and CXCL10 in the urban popu-
lation compared to the rural population, underscoring the 
complexity of immune interactions. After data reduction with 
principal component analysis, the urban environment had higher 
values for PC3, implying lower representation of the classi-
cal inflammatory mediators IL1-beta, IL-6 and TNF-alpha. 
This may suggest that, in our study, the urban setting is 
associated with less classical inflammation than the rural 
environment. Despite the difficulty in interpreting the principal 
components, it is clear that the inflammatory profiles of 
individuals in the rural and urban settings are different.
Our study had a number of limitations, which we have 
considered. The analytes were measured in plasma and generally, 
levels of most cytokines are low in plasma. This could have 
contributed to the inability to find any differences in the Th1, 
Th2 and Th17 cytokines. Stimulation of peripheral blood mono-
nuclear cells may have resulted in higher measurable levels of 
the analytes. Genetic factors influencing the immune system 
were not studied, however, the ethnic groups in the two settings 
are similar15. Also, many tests were performed with no formal 
adjustment for multiple testing, therefore, chance findings can-
not be ruled out. However, of the 30 analytes tested, 10 showed 
evidence of differing between the rural and urban settings at 
p<0.05 (more than the 30 x 0.05=1.5 that we would expect to 
see by chance alone).
Taken together, our exploratory work on inflammatory 
analytes suggests that investigating differences in inflammatory 
profiles between rural and urban populations is complex but 
differences in these two populations exist. This could have 
broad implications for health such as susceptibility to infec-
tions and response to vaccines. However, the focus for this study 
was on the implications for cardiometabolic risk. Considering 
that inflammation correlates with some metabolic diseases, 
inflammation may be one of the pathways to explain the differ-
ence in cardiometabolic diseases between the urban and rural 
environments.
Data availability
Underlying data
LSHTM Data Compass: Data supporting “Profiles of inflam-
mation in rural and urban Uganda”. https://doi.org/10.17037/
DATA.0000245925.
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This project contains the following underlying data:
-  Inflammation_data.csv
-  Inflammation_data_codebook.html
Extended data
LSHTM Data Compass: Data supporting “Profiles of inflam-
mation in rural and urban Uganda”. https://doi.org/10.17037/
DATA.0000245925.
This project contains the following extended data:
-  Consent_forms.zip (consent forms and information 
sheets)
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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The authors investigated the association of several inflammatory markers with selected 
cardiovascular risk markers in apparently healthy subjects aged ≥ 10 years. Data obtained from 
rural and urban residents were evaluated employing different statistical approaches. Differences in 
presentation of some classical inflammatory mediators, chemoattractant, and vasoactive peptides 
have been observed; and correlations between pro-inflammatory analytes and cardiometabolic 
risk markers were reported. It has been concluded that different expressions of certain pro-
inflammatory mediators may have important health consequences and may contribute to an 
increased cardiometabolic risk in the urban environment. 
 
This is a potentially interesting study with some novelty. However, in my opinion, several 
weaknesses should be addressed before the study can proceed to indexing. 
 
Major comments: 
 
Introduction - 
 
Last paragraph: Motivation to analyze 30 different inflammatory markers in apparently healthy 
subjects should be explained. A hypothesis is missing – it should be clearly formulated. 
 
Methods, Results - 
 
I have concerns about the clinical interpretation of data obtained using the raw fluorescence 
intensity values of the analytes instead of using the returned concentrations. As follows from the 
advocation of this attitude, several measured markers were out of the standard range, e.g. below 
the sensitivity of the assay or even below the blank. The authors state that analyses using 
fluorescence intensities do not require censoring and provide more statistical power than analysis 
based on concentrations. I suppose that this attitude is feasible from the mathematical (statistical) 
point of view but irrelevant clinically. The physician evaluates concentrations or activities of 
analytes with the knowledge of their reference ranges - not the physical units used for 
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quantification as these are clinically uninterpretable. Even if the calibration curves would be linear. 
As the calibration curves for 30 different analytes are not identical, the same fluorescence returns 
different concentrations, even by order(s) of magnitude. In biomedical research, statistics is an 
auxiliary method, helping in the interpretation of the results. An interpretation should be strictly 
done in a clinical context on clinically relevant data, and only these clinically relevant data (not 
physical units) should be statistically evaluated. 
 
I suppose that the problem lies in the fact that several markers were under the detection limit of 
the assay (what could be anticipated as healthy subjects were studied). The statistician did not 
perceive the fact as a problem since the fluorescent units were available. The physicians did not 
comment on the fact that they evaluate concentrations and not fluorescent units. A physicist or 
biochemist who would get alert learning that fluorescence is to be evaluated and serve as a basis 
for clinical interpretation was probably not in the team. This, unfortunately, resulted in an 
extended statistical exercise that has no clinical relevance. If the analyte is under the detection 
limit of the assay it should be acknowledged. These data should be handled as unavailable instead 
of looking for a way how to overcome this reality eventually leading to misinterpretation. 
 
I suppose that the authors should give the data as concentrations (not fluorescence units); for 
each analyte, the number of subjects in whom valid concentrations were obtained should be 
indicated; numbers of should be given also in the case of simple correlations performance; and 
multivariate analyses should be conducted using selected data sets – those which yielded reliable 
concentrations in all, or a vast majority of the probands. (the PCA is robust, among others, in the 
handling of missing data, allowing for a reasonable arbitrary selection of what percentage of data 
in the set must be available to include the variable into the analysis. And probably the missing 
data should be random, not always missing in the same subjects). 
 
Even though in the dot plots the 95% Hoteling’s ellipse is not depicted, it is obvious that subjects 
(e.g., in the right lower corner of Figure 1) are major outliers. In the case that such outliers are 
retained in the analysis, their characteristics should be given and it should be explained why they 
were retained in the analysis, and what changed after their exclusion. 
 
It is not stated whether the median or the mean of the sum of fluorescence signal intensities has 
been used, but it is rather marginal in the context. 
 
It is not indicated how the sample size was calculated thus, what was the adequate expected 
power. 
 
Minor comments: 
 
Methods - 
 
The authors should indicate whether standard laboratory methods were used to quantify blood 
chemistry variables, and the brand and the manufacturer of the employed analyzer(s). 
 
Results - 
 
Table 1: Regarding decimals, for clearness, FPG, BP, and BMI data should be reported in a manner 
generally used in clinics. Indication of decimals or more decimals than necessary does not add to 
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the scientific value of the paper and is rather confusing for the reader.
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No
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